BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2003
View Archived Issues
OBI-1 undergoes testing in hemophilia A patients
Read More
Phase II trial of repifermin for chronic venous ulcers does not meet primary endpoint
Read More
Safety and efficacy of LymphoStat-B for SLE evaluated in phase II clinical trial
Read More
FDA advisory committee recommends expanded label for Provigil
Read More
Clinical evaluation of dopamine D3 receptor as a target
Read More
Mood-stabilizing properties described for anticonvulsants
Read More
Antagonists of VR1, mGluR1 and/or mGluR5 receptors claimed by Euroceltique
Read More
Novel muscarinc M2 agonists with potential utility in cardiovascular disorders
Read More
Boehringer Ingelheim presents new HCV NS3 inhibitors
Read More
New alphavbeta6 integrin inhibitors and their use described by Merck KGaA
Read More
Guanidine-based melanocortin MC4 agonists covered by Chiron patent
Read More
French team prepares and tests new insulin mimetics
Read More
Preliminary phase III results for modified-release indiplon
Read More
Milestone achievement in Affinium/Pfizer alliance
Read More
Five-year CHAMPIONS data support early initiation of Avonex for MS
Read More
Thyrogen indication extended in Europe
Read More
Amendment to Epimmune contract to include smallpox as target
Read More
Merck exercises option in Celltech PDE4 collaboration
Read More
Integrin antagonists useful for angiogenesis-related ocular diseases
Read More
Additional funding for development of MVA-BN as smallpox vaccine
Read More
Second-generation peptide deformylase inhibitors for RTIs presented at ICAAC meeting
Read More
Characterization of new 5-HT1B antagonist reveals anxiolytic/antidepressant properties
Read More
Successful interim analysis of phase II alfimeprase study
Read More
Major study to directly compare PEG-Intron and Pegasys for HCV
Read More
Semisynthetic ketolide antibacterial agents designed at J&J and Kosan
Read More
HuMax-EGFr tested in a new phase I/II trial in head and neck cancer
Read More
New inhibitors of dipeptidyl-peptidase IV with blood glucose-lowering activity
Read More